TrialClinical cardiology2018

Blockade of the renin-angiotensin-aldosterone system in patients with arrhythmogenic right ventricular dysplasia: A double-blind, multicenter, prospective, randomized, genotype-driven study (BRAVE study).

Elodie Morel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.